home / stock / opti:cc / opti:cc news

OPTI:CC News and Press, Optimi Health Corp. From 09/09/22

Stock Information
Company Name: Optimi Health Corp.
Stock Symbol: OPTI:CC
Market: CNQC
Website: optimihealth.ca
Menu
OPTI:CC OPTI:CC Quote OPTI:CC Short OPTI:CC News OPTI:CC Articles OPTI:CC Message Board
Get OPTI:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
OPTI:CC - Optimi Health and Avida Global Sign First International Mushroom Supply Agreement

Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) is a homegrown Canadian company producing natural, scalable and accessible psychedelic and functional mushrooms and synthetic formulations for transformational human experiences. The company is on Health Canada’s list of appr...
OPTI:CC - Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History

VANCOUVER, British Columbia, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has completed what it believes to be the largest legal natural psilocyb...

OPTI:CC - Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida Global

VANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psyche...

OPTI:CC - Psychedelics May Make People Less Afraid of Death

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 7, 2022 – According to a new survey by Johns Hopkins Medicine researchers, people’s attitudes toward death change after a psychedelic drug experience and a non-d...
OPTI:CC - Optimi Health Provides Progress Report On Year Of Commercialization

Company set to introduce psychedelic product catalogue showcasing in-house EU-GMP manufacturing expertise VANCOUVER, British Columbia, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Comp...

OPTI:CC - Psychedelics Use Among Young Adults Reaches All-Time High

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 1, 2022 – Young adults are using more hallucinogens than ever.  According to a National Institute of Health survey, the amount of people between age 19 to 30 who repor...

OPTI:CC - Optimi Health Enters Into International Collaborative Research and Supply Agreement With Promises Innovative Recovery Center

VANCOUVER, British Columbia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psyched...
OPTI:CC - Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreements for Functional Mushroom Supplements and Appoints Chief Financial Officer to its Board of Directors

VANCOUVER, British Columbia, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psyched...

OPTI:CC - Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health

VANCOUVER, British Columbia, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psyched...

OPTI:CC - Optimi Health Unveils Canada's First Natural Therapeutic Psilocybin Product For Approved Patients

Blue Serenity brings science and compassion together, will cement Thomas Hartle’s legacy as a Canadian psychedelic icon Optimi and Hartle to host press conference today at 1:00 PM EST VANCOUVER, British Columbia, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Optimi Health Cor...
Previous 10 Next 10